Effects of Cyanamide, an aldehyde dehydrogenase type 2 inhibitor, on glyceryl trinitrate- and isosorbide dinitrate-induced vasodilation in rabbit excised aorta and in anesthetized whole animal

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 4, 2013, Pages 556-563

  Ishibashi, Takaharu ^a   Nomura Nakamoto, Mihoko ^a   Abe, Fusae ^a   Masuoka, Takayoshi ^a   Imaizumi, Noriko ^a   Yoshida, Junko ^a   Kawada, Tomie ^b   Nishio, Matomo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Cyanamide; Glyceryl trinitrate; Isosorbide dinitrate; Nitrite; Rabbit

Indexed keywords

CYANAMIDE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; MILLISTROL; NITRITE; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA MEDIA; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DOSE RESPONSE; DRUG MEGADOSE; EX VIVO STUDY; HEART MUSCLE RELAXATION; HYPOTENSION; INDUCED HYPOTENSION; MEDIAN EFFECTIVE CONCENTRATION; METABOLISM; NONHUMAN; SIGNAL TRANSDUCTION; TENSION;

ALDEHYDE DEHYDROGENASE; ANESTHESIA; ANIMALS; AORTA, THORACIC; CYANAMIDE; ENZYME INHIBITORS; ISOSORBIDE DINITRATE; NITRITES; NITROGLYCERIN; RABBITS; VASODILATION; VASODILATOR AGENTS;

EID: 84876929709     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00855     Document Type: Article

References (34)

1. Ahlner J, Andersson RG, Torfgård K, Axelsson KL. Organic nitrate esters: clinical use and mechanisms of actions. Pharmacol. Rev., 43, 351-423 (1991).
2. Münzel T, Feil R, Mülsch A, Lohmann SM, Hofmann F, Walter U. Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate-dependent protein kinase [corrected]. Circulation, 108, 2172-2183 (2003).
3. Chen Z, Stamler JS. Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase. Trends Cardiovasc. Med., 16, 259-265 (2006).
4. Mayer B, Beretta M. The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles. Br. J. Pharmacol., 155, 170-184 (2008).
5. Münzel T, Daiber A, Gori T. Nitrate therapy: new aspects concerning molecular action and tolerance. Circulation, 123, 2132-2144 (2011).
6. Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, Mülsch A, Münzel T. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol. Pharmacol., 66, 1372-1382 (2004).
7. Minamiyama Y, Takemura S, Akiyama T, Imaoka S, Inoue M, Funae Y, Okada S. Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels. FEBS Lett., 452, 165-169 (1999).
8. Bryan NS, Fernandez BO, Bauer SM, Garcia-Saura MF, Milsom AB, Rassaf T, Maloney RE, Bharti A, Rodriguez J, Feelisch M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat. Chem. Biol., 1, 290-297 (2005).
9. Dejam A, Hunter CJ, Schechter AN, Gladwin MT. Emerging role of nitrite in human biology. Blood Cells Mol. Dis., 32, 423-429 (2004).
10. - contribute to apparent steady-state arteriovenous differences in anesthetized animals. Biol. Pharm. Bull., 34, 528-537 (2011).
11. Ishibashi T, Hamaguchi M, Kato K, Kawada T, Ohta H, Sasage H, Imai S. Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle. Naunyn Schmiedebergs Arch. Pharmacol., 347, 553-561 (1993).
12. Ishibashi T, Himeno M, Imaizumi N, Maejima K, Nakano S, Uchida K, Yoshida J, Nishio M. NO(x) contamination in laboratory ware and effect of countermeasures. Nitric Oxide, 4, 516-525 (2000).
13. Ishibashi T, Miwa T, Shinkawa I, Nishizawa N, Nomura M, Yoshida J, Kawada T, Nishio M. Quantifying nanomolar levels of nitrite in biological samples by HPLC-Griess method: special reference to arterio-venous difference in vivo. Tohoku J. Exp. Med., 215, 1-11 (2008).
14. Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto T, Kitagawa K, Nakayama KI, Hess DT, Stamler JS. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc. Natl. Acad. Sci. U.S.A., 102, 12159-12164 (2005).
15. Mukerjee N, Pietruszko R. Inactivation of human aldehyde dehydrogenase by isosorbide dinitrate. J. Biol. Chem., 269, 21664-21669 (1994).
16. Kawada T, Ishibashi T, Sasage H, Kato K, Imai S. Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atriopeptin in aortae of the rat, guinea-pig and rabbit. Gen. Pharmacol., 25, 1361-1371 (1994).
17. Zhang J, Chen Z, Cobb FR, Stamler JS. Role of mitochondrial aldehyde dehydrogenase in nitroglycerin-induced vasodilation of coronary and systemic vessels: an intact canine model. Circulation, 110, 750-755 (2004).
18. Badejo AM Jr, Hodnette C, Dhaliwal JS, Casey DB, Pankey E, Murthy SN, Nossaman BD, Hyman AL, Kadowitz PJ. Mitochondrial aldehyde dehydrogenase mediates vasodilator responses of glyceryl trinitrate and sodium nitrite in the pulmonary vascular bed of the rat. Am. J. Physiol. Heart Circ. Physiol., 299, H819-H826 (2010).
19. Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD, Vasiliou V. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol. Rev., 64, 520-539 (2012).
20. Mackenzie IS, Maki-Petaja KM, McEniery CM, Bao YP, Wallace SM, Cheriyan J, Monteith S, Brown MJ, Wilkinson IB. Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans. Arterioscler. Thromb. Vasc. Biol., 25, 1891-1895 (2005).
21. Li Y, Zhang D, Jin W, Shao C, Yan P, Xu C, Sheng H, Liu Y, Yu J, Xie Y, Zhao Y, Lu D, Nebert DW, Harrison DC, Huang W, Jin L. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J. Clin. Invest., 116, 506-511 (2006).
22. Sakata S, Yoshihara T, Arima H, Shiraishi F, Oniki H, Takahashi-Yanaga F, Matsumura K, Sasaguri T. Differential effects of organic nitrates on arterial diameter among healthy Japanese participants with different mitochondrial aldehyde dehydrogenase 2 genotypes: randomised crossover trial. BMJ Open, 1, e000133 (2011).
23. Murphy TC, Arntzen R, Picklo MJ Sr. Nitrate-based vasodilators inhibit multiple vascular aldehyde dehydrogenases. Cardiovasc. Toxicol., 5, 321-332 (2005).
24. Beretta M, Wölkart G, Schernthaner M, Griesberger M, Neubauer R, Schmidt K, Sacherer M, Heinzel FR, Kohlwein SD, Mayer B. Vascular bioactivation of nitroglycerin is catalyzed by cytosolic aldehyde dehydrogenase-2. Circ. Res., 110, 385-393 (2012).
25. Tsou PS, Page NA, Lee SG, Fung SM, Keung WM, Fung HL. Differential metabolism of organic nitrates by aldehyde dehydrogenase 1a1 and 2: substrate selectivity, enzyme inactivation, and active cysteine sites. AAPS J., 13, 548-555 (2011).
26. Alnouti Y, Klaassen CD. Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol. Sci., 101, 51-64 (2008).
27. Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab. Pharmacokinet., 21, 357-374 (2006).
28. Kollau A, Hofer A, Russwurm M, Koesling D, Keung WM, Schmidt K, Brunner F, Mayer B. Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide. Biochem. J., 385, 769-777 (2005).
29. x concentration by isosorbide dinitrate, an organic nitrate ester. J. Cardiovasc. Pharmacol., 41, 40-48 (2003).
30. Mülsch A, Bara A, Mordvintcev P, Vanin A, Busse R. Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo. Br. J. Pharmacol., 116, 2743-2749 (1995).
31. Clermont G, Lecour S, Vergely C, Zeller M, Perrin C, Maupoil V, Bouchot O, Rochette L. Direct demonstration of nitric oxide formation in organs of rabbits treated by transdermal glyceryl trinitrate using an in vivo spin trapping technique. Fundam. Clin. Pharmacol., 17, 709-715 (2003).
32. Shirota FN, Goon DJ, DeMaster EG, Nagasawa HT. Nitrosyl cyanide, a putative metabolic oxidation product of the alcohol-deterrent agent cyanamide. Biochem. Pharmacol., 52, 141-147 (1996).
33. Mihic SJ, Harris RA. Hypnotics and sedatives. Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th Eddition (Brunton L, Chabner B, Knollman B eds.). McGraw Hill Medical, New York, pp. 527-564 (2011).
34. Patel PM, Patel HH, Roth DM. General anesthetics and therapeutic gases. Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th Eddition (Brunton L, Chabner B, Knollman B eds.). McGraw Hill Medical, New York, pp. 527-564 (2011).